Bame, E., Tang, H., Burns, J. C., Arefayene, M., Michelsen, K., Ma, B., Marx, I., Prince, R., Roach, A. M., Poreci, U., Donaldson, D., Cullen, P., Casey, F., Zhu, J., Carlile, T. M., Sangurdekar, D., Zhang, B., Trapa, P., Santoro, J., Muragan, P., Pellerin, A., Rubino, S., Gianni, D., Bajrami, B., Peng, X., Coppell, A., Riester, K., Belachew, S., Mehta, D., Palte, M., Hopkins, B. T., Scaramozza, M., Franchimont, N., & Mingueneau, M. (2021). next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clinical & translational immunology, 10(6), n/a. http://access.bl.uk/ark:/81055/vdc_100133620880.0x000010